Download helpful information about OxyContin

• The OxyContin Medication Guide, which gives you important safety information about OxyContin
View the Medication Guide


• The OxyContin Full Prescribing Information
View the Full Prescribing Information

Risk Evaluation and Mitigation Strategy (REMS)

OxyContin is subject to the REMS for opioid analgesics

The goal of the REMS is to reduce serious adverse outcomes resulting from inappropriate prescribing, abuse, and misuse of opioid analgesics, while maintaining patient access to these medications. Adverse outcomes of concern include addiction, unintentional overdose, and death.

• FDA has required a REMS for opioid analgesics
• Purdue Pharma is a member of the REMS Program Companies

OxyContin should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain.

Documentation and maintenance of careful prescribing and treatment records are essential, and should include:

• Physician and patient agreement
• Proper assessment of the patient
• Proper prescribing practices
• Periodic reevaluation of therapy
• Proper dispensing and correct storage and handling
• Careful record keeping of prescribing information, including quantity, frequency, and renewal requests, is strongly advised
• Providing patient and/or caregiver with the Medication Guide
• Reviewing the Opioid REMS Patient Counseling Guide with the patient and/or caregiver at the time of prescribing

For more information, including REMS-compliant educational CME/CE programs on safe prescribing of REMS for opioid analgesics, visit opioidanalgesicrems.com.